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Underdiagnosis of asthma and COPD: 
is the general practitioner to blame?
C. van Weel
For a substantial number of patients with asth-
ma and chronic obstructive pulmonary disease
(COPD) in the community their condition has not
been diagnosed. Potentially, this failure of diagno-
sis – ‘under-diagnosis’ – can severely hamper or
postpone effective treatment and this makes under-
diagnosis such an important issue in the pursuit of
optimal care of patients with asthma or COPD.
Early detection and diagnosis of illness in the com-
munity is the professional domain of the general
practitioner (GP, in North America referred to as:
family physician) and before embarking in more
detail on under-diagnosis of asthma and COPD, it
is important to consider the broader context in
which illness in general is perceived by individu-
als and presented and diagnosed.
Primary care provides the interface between
community and professional medical care. Of the
many signs/symptoms experienced in the commu-
nity, only about 10% are ever presented to the GP
[1, 2], so most remain un-presented, hence un-di-
agnosed and consequently not professionally treat-
ed. Under-diagnosis is a feature of virtually all dis-
eases, including those where treatment is, from a
medical professional opinion, highly desirable [2].
This phenomenon is known as the ‘iceberg’ of
morbidity, with the tip of the iceberg indicating the
number of cases professionally identified. The
professional role of the GP is to identify early
signs and symptoms of morbidity, but also to
coach the patient in seeking professional care for
relevant health problems and rely on self-care
where appropriate [3]. The fact that patients do not
present experienced health problems is not neces-
sarily negative. In fact it reflects patients’ autono-
my and self-reliance, which are important societal
values. But this causes a true dilemma for the GP
to rock the iceberg and pursue the identification of
not routinely presented morbidity. Unless there is
sound evidence that this yields better outcome of
care, GPs are professionally reluctant to practice
active case-finding.
This paper reviews the problem of under-diag-
nosis of asthma and COPD in general practice and
the contributing factors. The review is based on
empirical data from research of the Nijmegen De-
partment of General Practice: Ongoing Morbidity
Surveillance [4,5] and a longitudinal study pro-
gramme of early detection and intervention of
asthma and COPD in general practice, the Diagno-
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ABSTRACT: Underdiagnosis of asthma and COPD: is the
general practitioner to blame? C. van Weel.
This paper analyses, on the basis of a series of gener-
al practice studies, the under-diagnosis   of asthma and
chronic obstructive pulmonary disease (COPD) in terms
of the magnitude of the problem, and the implications and
factors that contribute to adequate diagnosis. Most pa-
tients with chronic or persistent respiratory signs/symp-
toms present to the general practitioner (GP) and it is the
GP who is usually responsible for diagnosis and treat-
ment. An inherent problem of ‘early’ diagnosis of asthma
and COPD is that signs and symptoms that patients expe-
rience must be followed over time to establish their chron-
ic-recurrent nature. This approach fits well – in itself –
with the general practice principle of continuity of care.
The analysis was mainly based on the “Diagnosis, In-
tervention and Monitoring of COPD and Asthma (DIM-
CA)” study that investigated the hypothesis that early in-
tervention would enhance the effectiveness of (inhaled cor-
ticosteroid) intervention, and for this reason required de-
tection of patients in as early a stage of their asthma/COPD
as possible.
Despite the fact that asthma and COPD are being di-
agnosed more frequently, the proportion of diagnosed to
undiagnosed cases has remained stable over the years,
pointing to an increase in prevalence in the population. A
major factor in under-diagnosis is the fact that patients
experience symptoms, but do not present these symptoms
to a physician. Reluctance to present symptoms appears to
be related to reluctance to take on the role of patient and
take (inhaled) medication. This points to patient-percep-
tions and -values as an important factor in under-diagno-
sis. This finding is all the more relevant in the light of in-
creasing indications of the value of early treatment.
For GPs and primary care these findings are impor-
tant. They imply that early intervention will only be possi-
ble when a case-finding approach, that evaluates pro-ac-
tive outcome of respiratory signs/symptoms, is combined
with an analysis of patients’ perceptions and values.
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Fig. 1. – Natural growth of pulmonary function from birth to adulthood, followed by: (a) physiological decline (upper line); (b) pathological
decline (lower line). Inserted above lower line: the effect of intervention.
sis, Intervention and Monitoring of COPD and
Asthma (DIMCA) study [6]. The exploration will
focus on:
• the implications of under-diagnosis;
• the magnitude of the problem;
• the factors that contribute.
Implications of under-diagnosis: 
the hypothesis
For many years the iceberg phenomenon of
asthma and COPD has been well documented [7]
raising concern about the long-term consequences
of delayed treatment, in particular the irreversible
loss of pulmonary function (figure 1). This con-
cern was fuelled by the finding of our group in the
early 1990s that irreversible loss of pulmonary
function was a feature in patients with
asthma/COPD in general practice [8]. Particularly
when additional treatment with inhaled anti-in-
flammatory treatment modified this development
[9], the potential health gains, in terms of pul-
monary function, of long-term intervention in
asthma/COPD could be expected. This made it
particularly relevant to revisit the problem of un-
der-diagnosis of asthma and COPD. The DIMCA
study was based on the hypothesis that early inter-
vention would enhance the effectiveness of (in-
haled corticosteroid) intervention (figure 1), and
for that reason detection of patients in as early a
stage of their asthma/COPD was required.
Effectiveness of early intervention: 
the DIMCA study
The DIMCA study was based on the practice
population of ten general practices in the 
Nijmegen region. Its objective was to assess the ef-
fectiveness of inhaled corticosteroid treatment on
symptoms, quality of life and in particular pul-
monary function in subjects with early signs and
symptoms of asthma or COPD. Selection therefore
included those with ‘minimal’ signs/symptoms
(figure 2). A 10% sample of the adults (aged
18–70 years) never diagnosed with asthma or
COPD before were invited to participate in the
case-finding phase. Case-finding followed two
consecutive steps: first, all subjects were screened
for signs/symptoms of asthma/COPD, and those
screening positive were monitored for up to two
years, to select patients for three intervention stud-
ies. The programme assessed: a) the effectiveness
of the inhaled corticosteroid intervention for de-
fined groups of patients; and b) the effectiveness of
the early detection and treatment strategy, in com-
parison to normal care.
In just under half the subjects screened,
signs/symptoms of asthma/COPD were identified,
the large majority on the basis of symptoms. By
monitoring, this group could be divided into four
subgroups:
1) subjects with persistent, substantial airflow ob-
struction: 7% of the population;
2) subjects with accelerated decline of pulmonary
function: 12% of the population;
3) subjects with persistent mild signs/symptoms:
19% of the population;
4) subjects in whom no persistent signs/symp-
toms of their airways could be demonstrated:
12% of the population (screening ‘false posi-
tive’) [6].
Intervention with inhaled corticosteroids was
effective in the groups 1 and 2, and as a conse-
quence, the whole approach from screening
through monitoring to intervention was cost-effec-
tive. But the intervention in the group with persis-
tent signs/symptoms failed to be effective [10].
From this it could be concluded that: a) detection
of early cases of asthma/COPD is possible at the
expense of a one-in-four false positive diagnosis;
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and b) about 40 % of those selected do not benefit
from treatment.
Scale of the problem
The DIMCA study pointed to substantial un-
der-diagnosis. To put the issue in perspective it
was possible to compare the DIMCA findings of
1992 to the situation in Dutch general practice in
1977: in the 15-year period the prevalence of asth-
ma and COPD in general practice did increase
from about 2/1,000 to 5/1,000 [7,11]. The increase
in numbers of cases under treatment was, howev-
er, accompanied by an overall increase in popula-
tion prevalence, including an increase of unidenti-
fied cases. An important difference, however, be-
tween 1977 and 1992 was the relation of diagnosis
to severity of signs/symptoms. In 1977 under-di-
agnosis was present to a comparable degree in all
levels of severity [7], whereas in 1992 under-diag-
nosis was by and large restricted to the cases of
mild-severity [11].
Determinants of under-diagnosis
There are important physician-related factors
in under-diagnosis and guidelines have provided
the necessary knowledge and indicated the re-
quired skills to promote early detection. In partic-
ular spirometry is now available for diagnostic
routine in primary care to a large extent.
Patient-related factors in under-diagnosis, how-
ever, are less well documented. The DIMCA study
gave a number of important indications of the role
patient-factors may play. Participation in the study
demanded a strong commitment from the partici-
pants as it required not only their attendance at a
screening session but, during the two-year follow-
up programme, participants had to visit their GP
every three months, the long-function laboratory
twice a year and complete self-recording of
signs/symptoms in diaries. Yet, participation was
high, up until the time these same subjects were in-
vited to undergo treatment. More than half of them
declined the invitation of treatment [12], mainly ar-
guing that they did not consider themselves ill
enough and did not like taking drugs [13]. These –
by and large unsystematically collected – observa-
tions are in accordance with findings of two other
studies in the Nijmegen Academic General Practice
network. Bottema studied the prevalence of asthma
or COPD in general practice, and concluded that a
major reason for inadequate treatment was pa-
tients’ drop-out: a life-time asthma/COPD patient
career lasted between 1 and 10 years, with the ma-
jority clustering around 2–4 years [14]. This was
despite the fact that the practices studied, were uni-
versity-linked and made substantial efforts to en-
hance continuity of care. KOLNAAR et al. screened
adolescents and again discovered substantial num-
bers of undiagnosed asthma. All newly detected
cases and their parents were advised to contact their
GP and were offered an appointment. However, in
the end less than 30% in fact did visit their GP to
follow-up the findings at screening [5].
Under-diagnosis: conclusions
Under-diagnosis remains a substantial feature
of asthma and COPD, but it particularly involves
those with mild signs/symptoms, who have least to
gain from intervention. In the first place there is a
need for more evidence of the exact health im-
provements from interventions in patients with
mild signs/symptoms. If such evidence can be pre-
sented, it is quite likely that case-finding and treat-
ment will also be cost-effective. As long as this ev-
idence is lacking, case-finding should focus on pa-
tients with more severe signs/symptoms of asthma
or COPD.
Physician-related factors are important and ef-
forts to address these by better implementation of
guidelines and post-graduate training should be
continued. Better access to pulmonary function
testing facilities should also be promoted. In this
way, adequate diagnosis and treatment of asthma
and COPD can be further improved. But at the
same time it ought to be acknowledged that part of
the problem of under-diagnosis is related to diag-
nostic uncertainty, and coping with this uncertain-
ty will always be part of general practice.
This analysis has pointed to the fact that pa-
tient-related factors are also important in explain-
ing under-diagnosis, but these factors are poorly
understood and deserve more attention. It looks as
though patient autonomy and the wish to decline
effective treatment play a role. This hampers ade-
quate treatment, but at the same time these consid-
erations are related to important societal norms
and values. In conclusion, it is too simplistic to
blame under-diagnosis on professional shortcom-
ings of GPs. It is recommended to stimulate GPs to
act as clinical council of their patients with
(signs/symptoms of) asthma or COPD. In this
council professional and lay norms and values can
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Fig. 2. – Design of the Diagnosis, Intervention and Monitoring of
COPD and Asthma (DIMCA) study. From: [6].
be reviewed together. Even if it is not possible to
bridge the gap between the lay and professional
view the GP’s therapeutic partnership can at least
safeguard information for patients to decide upon.
This may not eradicate under-diagnosis, but guar-
antee that at least better use is made of what is pos-
sible.
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